News

Sings Common in People who Develop Early-Onset Colorectal Cancer
New cases of colorectal cancer in people under the age of 50 have been rising at an alarming rate over the past several decades. But younger adults aren’t routinely screened for colorectal cancer because the disease is still… Learn more
POSTED: 6/15/2023
A medical provider checking in with a patient.
Results from two NCI-supported studies relating to symptom management were among the significant findings presented at the June 2023 ASCO meeting. The findings, which both incorporated data from patient-reported outcomes (… Learn more
POSTED: 6/13/2023
A 3D rendering of the human gastrointestinal tract.
An estimated 153,020 men and women in the U.S. will be diagnosed with colorectal cancer in 2023, and 52,550 are expected to die of this disease. In two recent studies, researchers addressed the impact of overweight, obesity… Learn more
POSTED: 6/5/2023
Dr. Lori Minasian, Deputy Director, NCI DCP presents a Cancer HealthCast podcast
Dr. Lori Minasian, deputy director for the Division of Cancer Prevention at NCI, explains the promise of multi-cancer detection tests as a tool for screening for multiple cancers.
POSTED: 5/30/2023
Upcoming Events, Reminders
POSTED: 5/30/2023
A pregnant woman gettign an ultrasound.
A blood test that may detect cancer has received attention recently. But, unlike other blood tests being studied to screen for cancer, it wasn’t designed for that purpose. This test is a prenatal blood test that analyzes… Learn more
POSTED: 5/17/2023
Program News, Upcoming Events
POSTED: 5/16/2023
Aldred Scott Warthin, M.D., Ph.D.
More than a century after Aldred Scott Warthin, M.D., Ph.D., a pathologist at the University of Michigan, first suspected heredity lay behind one family’s numerous cancers, scientists have begun testing two experimental… Learn more
POSTED: 5/11/2023
An illustration depicting a human liver.
Despite intense research, liver cancer prevention remains a challenge. Current efforts are directed at underlying conditions that can significantly raise an individual’s risk, including hepatitis C infection, for which… Learn more
POSTED: 5/4/2023
AUTHOR: Susan Jenks
AACR Annual Meeting 2023
Eleven DCP/PREVENT presentations were delivered at the 2023 AACR Annual meeting, including: five poster sessions, one informational session with four staff from the NCI Division of Cancer Prevention, and two staff sessions… Learn more
POSTED: 4/28/2023
The NCI Division of Cancer Prevention Debuts Research Workforce Initiatives, Upcoming Events
POSTED: 4/25/2023
Symptoms of Colorectal Cancer: Changes in Bowel Habits, Blood or Changes in Stool, Pain and Bloating, Weight Loss
Early-onset colorectal cancer is considered relatively rare, but both incidence and mortality rates are increasing in people under age 50. NCI recently issued a special research request for grant applications in areas such… Learn more
POSTED: 3/22/2023
AUTHOR: Susan Jenks
PARTNRS is a strategic initiative to encourage and forge partnerships between oncologists and primary care providers to promote patient accrual into cancer symptom management trials funded by the NCI Community Oncology… Learn more
POSTED: 3/13/2023
Researchers have recruited the first vaccine candidates to one of two new prevention trials that seek to immunize high-risk individuals against cancers associated with Lynch syndrome, the most common cause of hereditary… Learn more
POSTED: 2/8/2023
AUTHOR: Susan Jenks
none
We present ULACNet-302 Estudio Oportunidad: An opportunity to improve the health of women living with HIV, Recruitment strategies for the ULACNet 201 study in Puerto Rico, and Use of a mobile application as a strategy to… Learn more
POSTED: 1/30/2023
NCI funding graphic for CIN
The National Cancer Institute’s (NCI’s) Board of Scientific Advisors (BSA) recently approved two new concept proposals aimed at expanding potential prevention interventions.
POSTED: 1/10/2023
Cover of the Jounal of the National Cancer Institute Monograph, 2022, Number 60..
A JNCI monograph on Engaging Older Adults in Cancer Clinical Trials Conducted in the National Cancer Institute Clinical Trials Network is available now. The articles, developed through working groups formed for an NCI… Learn more
POSTED: 12/21/2022
Cover of the December 2022 CP-CTNet Newsletter

Staff Highlight, DMACC Updates (Data Management and Reporting Unit, CP-CTNET DMACC Public Website and Portal Gateway Update, Clinical Trials Auditing Unit, Administrative and Coordinating Unit), In Memoriam, and… Learn more
POSTED: 12/16/2022
Doctor viewing mammography image on screen.
This month’s Research Highlights focuses on provider and patient beliefs about mammogram screening frequency, and separately, provider barriers to engaging in shared decision-making with high-risk patients about the use of… Learn more
POSTED: 11/28/2022
The National Cancer Institute Division of Cancer Prevention has released three Funding Opportunity Announcements to accept applications to create the Cancer Screening Research Network (CSRN). The CSRN will conduct rigorous… Learn more
POSTED: 11/21/2022
An infographic detailing CASCADE cervical cancer prevention.
Cervical cancer can be prevented by HPV vaccination and by screening for and treating precancerous lesions. Yet, millions of women globally remain at high-risk for developing cervical cancer. This is especially true for… Learn more
POSTED: 11/14/2022
AUTHOR: Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Image of breast cancer tumor in microenvironment.
This issue of Research Highlights focuses on how cells progress to become breast cancer, and separately, how breast cancer may spread. Understanding these transitional moments can help researchers keep invasive cancer from… Learn more
POSTED: 10/24/2022
Screen capture of the CP-CTNet September 2022 Newsletter
Featured Article: CP-CTNet Cross Network Study: Lynch Syndrome. Inherited susceptibility to cancer involves defects in genes that normally function to suppress the formation of tumors. One such syndrome was recognized by… Learn more
POSTED: 9/30/2022
A woman wearing headphones taking a hearing test.
More than half of cancer survivors who were treated with chemotherapy for the four most common types of cancer experienced clinically significant hearing loss and tinnitus after treatment, according to new research.
Learn more
POSTED: 9/27/2022
AUTHOR: Susan Jenks